Aperio Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $84.5M | Buy |
988,130
+99,497
| +11% | +$8.23M | 0.25% | 65 |
|
|
2020
Q3 | $68.6M | Buy |
888,633
+87,532
| +11% | +$6.67M | 0.23% | 74 |
|
|
2020
Q2 | $58.7M | Buy |
801,101
+115,136
| +17% | +$8.18M | 0.22% | 84 |
|
|
2020
Q1 | $45.5M | Buy |
685,965
+200,620
| +41% | +$14.1M | 0.2% | 90 |
|
|
2019
Q4 | $33.4M | Sell |
485,345
-25,611
| -5% | -$1.75M | 0.12% | 192 |
|
|
2019
Q3 | $37.6M | Buy |
510,956
+28,651
| +6% | +$2.08M | 0.15% | 150 |
|
|
2019
Q2 | $34.6M | Buy |
482,305
+40,575
| +9% | +$2.88M | 0.14% | 159 |
|
|
2019
Q1 | $30.3M | Sell |
441,730
-75,588
| -15% | -$4.88M | 0.13% | 168 |
|
|
2018
Q4 | $30.8M | Sell |
517,318
-30,659
| -6% | -$1.92M | 0.16% | 142 |
|
|
2018
Q3 | $36.7M | Buy |
547,977
+31,588
| +6% | +$2.1M | 0.16% | 141 |
|
|
2018
Q2 | $33.5M | Sell |
516,389
-45,077
| -8% | -$2.95M | 0.16% | 144 |
|
|
2018
Q1 | $40.2M | Buy |
561,466
+27,696
| +5% | +$1.99M | 0.2% | 109 |
|
|
2017
Q4 | $40.3M | Buy |
533,770
+58,858
| +12% | +$4.3M | 0.2% | 106 |
|
|
2017
Q3 | $34.6M | Buy |
474,912
+13,135
| +3% | +$947K | 0.2% | 112 |
|
|
2017
Q2 | $34.2M | Buy |
461,777
+80,567
| +21% | +$5.98M | 0.21% | 104 |
|
|
2017
Q1 | $27.9M | Buy |
381,210
+24,305
| +7% | +$1.7M | 0.19% | 117 |
|
|
2016
Q4 | $23.4M | Sell |
356,905
-56,524
| -14% | -$3.88M | 0.18% | 123 |
|
|
2016
Q3 | $30.7M | Buy |
413,429
+19,883
| +5% | +$1.47M | 0.22% | 102 |
|
|
2016
Q2 | $28.8M | Buy |
393,546
+12,558
| +3% | +$894K | 0.23% | 102 |
|
|
2016
Q1 | $26.9M | Buy |
380,988
+8,782
| +2% | +$584K | 0.23% | 101 |
|
|
2015
Q4 | $24.8M | Buy |
372,206
+9,186
| +3% | +$611K | 0.23% | 101 |
|
|
2015
Q3 | $23M | Sell |
363,020
-3,722
| -1% | -$243K | 0.23% | 97 |
|
|
2015
Q2 | $24M | Buy |
366,742
+11,874
| +3% | +$805K | 0.25% | 87 |
|
|
2015
Q1 | $24.6M | Buy |
354,868
+16,760
| +5% | +$1.16M | 0.28% | 82 |
|
|
2014
Q4 | $23.4M | Buy |
338,108
+24,633
| +8% | +$1.66M | 0.29% | 73 |
|
|
2014
Q3 | $20.4M | Buy |
313,475
+8,481
| +3% | +$559K | 0.28% | 76 |
|
|
2014
Q2 | $20.8M | Buy |
304,994
+5,756
| +2% | +$386K | 0.3% | 68 |
|
|
2014
Q1 | $19.4M | Buy |
+299,238
| New | +$18.9M | 0.27% | 62 |
|
|
2013
Q4 | – | Sell |
-253,134
| Closed | -$16.2M | – | 60 |
|
|
2013
Q3 | $15M | Buy |
253,134
+31,648
| +14% | +$1.88M | 0.29% | 59 |
|
|
2013
Q2 | $12.7M | Buy |
+221,486
| New | +$13.1M | 0.3% | 58 |
|
Other funds holding CL
Aperio Group's CL Position: Q4 2020 in Review
Aperio Group increased its Colgate-Palmolive (CL) stake by 11% in Q4 2020, buying an estimated $8.23M and bringing the position to 988,130 shares worth $84.5M. The position accounts for 0.25% of the portfolio, ranked #65.
Aperio Group first reported a position in CL in Q2 2013 and has held it in 30 quarters since. 1,651 funds tracked by Wall St. Rank hold CL as of Q4 2020.
- Aperio Group held 988,130 shares of Colgate-Palmolive worth $84.5M as of Q4 2020.
- Aperio Group bought 99,497 Colgate-Palmolive shares in Q4 2020, an estimated $8.23M.
- Colgate-Palmolive made up 0.25% of Aperio Group's portfolio in Q4 2020, its #65 holding.
- Aperio Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 30 quarters since.
- 1,651 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.